Literature DB >> 28457995

Schistosoma mansoni: Off-target analyses using nonspecific double-stranded RNAs as control for RNAi experiments in schistosomula.

Sandra Grossi Gava1, Naiara Clemente Tavares1, Anna Christina de Matos Salim1, Flávio Marcos Gomes de Araújo1, Guilherme Oliveira2, Marina Moraes Mourão3.   

Abstract

RNA interference is a well established and widely used reverse genetic tool available for gene functional studies in trematodes. This technique requires the use of nonrelevant double-stranded RNA as control. However, several authors have reported inconsistencies associated with RNAi. We used RNASeq to analyze genes affected by nonspecific dsRNA exposure. We found only few genes presenting altered expression in schistosomula exposed to GFP or mCherry nonspecific-dsRNAs, most of them encoding uncharacterized proteins. Correlation analysis revealed that there are more differences among biological replicates, than due to treatment with nonspecific controls. These observations are of key relevance to other RNAi gene function assessment in other organisms.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nonspecific controls; Off-target; RNA interference; RNASeq; Schistosoma mansoni

Mesh:

Substances:

Year:  2017        PMID: 28457995     DOI: 10.1016/j.exppara.2017.04.011

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  2 in total

1.  Effects of programmed cell death protein 10 on fecundity in Schistosoma japonicum.

Authors:  Yan-Ru Gao; Ji-Hong Xu; Chun-Lian Tang; Zhou Cai; Qiong Wu; Ying Xiong; Li-Xia Wang
Journal:  Parasitol Res       Date:  2020-03-09       Impact factor: 2.289

2.  A metalloprotease produced by larval Schistosoma mansoni facilitates infection establishment and maintenance in the snail host by interfering with immune cell function.

Authors:  Jacob R Hambrook; Alèthe L Kaboré; Emmanuel A Pila; Patrick C Hanington
Journal:  PLoS Pathog       Date:  2018-10-29       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.